Abstract 16265: Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 With a Monoclonal Antibody REGN727/SAR236553, Effectively Reduces Low-Density-Lipoprotein Cholesterol, as Mono or Add-on Therapy in Heterozygous Familial and Non Familial Hypercholesterolemia
暂无分享,去创建一个
E. Stein | S. Mellis | R. Wu | G. Swergold | William M. Smith | Yunling Du | Douglas Logan | E. Gasparino | Cheryle Webb | Th.F. Krans